Drug class
Macrolide antibacterial; 50S ribosomal subunit inhibitor
Mechanism of action
Binds the 50S bacterial ribosomal subunit and inhibits protein synthesis by interfering with peptide-chain elongation and translocation.
General use cases
- Treatment of infections caused by josamycin-susceptible bacteria, including selected respiratory, skin/soft-tissue and atypical bacterial infections in countries where authorised; use should follow local susceptibility and antimicrobial guidance
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
